Ignite Creation Date:
2024-05-05 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00514085
Status:
COMPLETED
Last Update Posted:
2023-08-04
First Post:
2007-08-08
Brief Title:
Interleukin-21 in Treating Patients With Metastatic or Recurrent Malignant Melanoma
Sponsor:
NCIC Clinical Trials Group
Organization:
Canadian Cancer Trials Group
Organization Data
Organization:
Canadian Cancer Trials Group
Class:
NETWORK
Study ID:
I189
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
NCIC Clinical Trials Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ZymoGenetics | INDUSTRY |